Nazih Moufarrij, MD
Neurological Surgery · Wichita, KSNPI 1871590646
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 88.1% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $2,833 and has fallen 84.8% since, to $432 in 2024.
Across 162 payments — averaging $30.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$147
- Boston Scientific$112
- Intrinsic Therapeutics$85
- Microtransponder, Inc.$49
- Aesculap, Inc.$39
- plus $163 from 8 others
What the payments were for
- Speaking & faculty fees$2,50050%
- Travel & lodging$59612%
- Food & beverage$1,87738%
- Entertainment$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 142 | $4,396 |
| Abbott | 2 | $147 |
| Boston Scientific | 3 | $112 |
| Intrinsic Therapeutics | 2 | $85 |
| Microtransponder, Inc. | 1 | $49 |
| Aesculap, Inc. | 2 | $39 |
| Inspire Medical Systems, Inc. | 2 | $39 |
| Hologic Sales And Service, LLC | 2 | $38 |
| Ulrich Medical USA, Inc. | 1 | $17 |
| Orthofix Medical, Inc. | 1 | $16 |
| Portola Pharmaceuticals, LLC | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| AbbVie | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS$2,500
- KYPHON EXPRESS II KYPHOPAK TRAY$503
- INTELLIS ADAPTIVESTIM$291
- PROCLAIM$101
How this compares
$4,991 in reported general payments places this provider in the 70th percentile of 63 neurological surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclobenzaprine Hcl | 12 | $68 |
| Gabapentin | 16 | $65 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Wichita
- Raymond GrundmeyerWichita$1.9M
- Matthew HenryWichita$1.9M
- John DickersonWichita$1.9M
- Zsolt ZadorWichita$3K
- Thomas FrimpongWichita$2K
- Ashley BarksWichita$952
- James WeimarWichita$106
- Christian LothesWichita$92
- Frank HolladayKansas City$349K
- Koji EbersoleKansas City$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.